标题 |
Should CAR-T cell therapy be considered a standard of care for patients with refractory diffuse large B-cell lymphoma in second line treatment?
CAR-T细胞疗法是否应该被视为二线治疗难治性弥漫性大B细胞淋巴瘤患者的标准护理?
|
网址 | |
DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
求助人 | |
下载 | 求助已完成,仅限求助人下载。 |